tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

HCM Stock Latest News

Hutchmed, Innovent jointly announce NDA acceptance in China
The FlyHutchmed, Innovent jointly announce NDA acceptance in China
17d ago
HCM
Hutchmed downgraded to Hold from Buy at HSBC
PremiumThe Fly
Hutchmed downgraded to Hold from Buy at HSBC
1M ago
HCM
Hutchmed says NDA for Tazverik granted conditional approval in China
PremiumThe Fly
Hutchmed says NDA for Tazverik granted conditional approval in China
3M ago
HCM
HUTCHMED’s Strong Financial Performance and Strategic Growth Drive Buy Rating
PremiumRatings
HUTCHMED’s Strong Financial Performance and Strategic Growth Drive Buy Rating
3M ago
HCM
Hutchmed Reports Strong 2024 Growth and Profitability
PremiumCompany Announcements
Hutchmed Reports Strong 2024 Growth and Profitability
3M ago
HCM
Hutchmed sees FY25 Oncology/Immunology revenue $350M-$450M
PremiumThe FlyHutchmed sees FY25 Oncology/Immunology revenue $350M-$450M
3M ago
HCM
Hutchmed reports FY24 EPS 22c vs. 59c last year
Premium
The Fly
Hutchmed reports FY24 EPS 22c vs. 59c last year
3M ago
HCM
Hutchmed/Innovent update on Phase 2/3 study of Fruquintinib+Sintilimab
Premium
The Fly
Hutchmed/Innovent update on Phase 2/3 study of Fruquintinib+Sintilimab
3M ago
HCM
Hutchmed completes enrollment of fanregratinib trial
PremiumThe Fly
Hutchmed completes enrollment of fanregratinib trial
4M ago
HCM
HUTCHMED Updates on Major Divestment in Shanghai Hutchison Pharmaceuticals
PremiumCompany Announcements
HUTCHMED Updates on Major Divestment in Shanghai Hutchison Pharmaceuticals
4M ago
6K
HCM
Hutchmed price target raised to $27 from $26 at BofA
PremiumThe Fly
Hutchmed price target raised to $27 from $26 at BofA
4M ago
HCM
Hutchmed announces NMPA approval for Orpathys supplemental new drug application
PremiumThe Fly
Hutchmed announces NMPA approval for Orpathys supplemental new drug application
5M ago
HCM
Hutchmed price target lowered to $26 from $30 at BofA
PremiumThe FlyHutchmed price target lowered to $26 from $30 at BofA
6M ago
HCM
Morning Movers: Neumora Therapeutics plummets after KOASTAL-1 misses endpoint
Premium
The Fly
Morning Movers: Neumora Therapeutics plummets after KOASTAL-1 misses endpoint
6M ago
HCM
MCD
Hutchmed announces NDA acceptance in China, payment from AstraZeneca
Premium
The Fly
Hutchmed announces NDA acceptance in China, payment from AstraZeneca
6M ago
AZN
HCM
Hutchmed divests 45% interest in Shanghai Hutchison for $608M
PremiumThe Fly
Hutchmed divests 45% interest in Shanghai Hutchison for $608M
6M ago
HCM
Hutchmed to receive milestone payment from Takeda
PremiumThe Fly
Hutchmed to receive milestone payment from Takeda
6M ago
HCM
TAK
Hutchmed announces BTD in China for Orpathys, Tagrisso combination
PremiumThe Fly
Hutchmed announces BTD in China for Orpathys, Tagrisso combination
6M ago
HCM
Hutchmed announces Elunate, Tyvyt NDA granted approval in China
PremiumThe Fly
Hutchmed announces Elunate, Tyvyt NDA granted approval in China
7M ago
HCM
Hutchmed to receive milestone payment following Takeda launch of Fruzaqla
PremiumThe FlyHutchmed to receive milestone payment following Takeda launch of Fruzaqla
7M ago
HCM
TAK
Hutchmed announces new, updated data from sovleplenib ESLIM-01 trial
Premium
The Fly
Hutchmed announces new, updated data from sovleplenib ESLIM-01 trial
8M ago
HCM
Hutchmed to receive $20M milestone payment from Takeda for Fruzaqla sales
Premium
The Fly
Hutchmed to receive $20M milestone payment from Takeda for Fruzaqla sales
8M ago
HCM
TAK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >